Research in dermatology comprises only a small portion of the total amount of money spent yearly on research in fields such as internal medicine, neurology and cancer. The need for interested and talented individuals to tackle the big challenges in dermatology is greater than ever before, and practitioners are looking at ways to make the most of limitations in funding, compensation and opportunities that stand in the way of recruiting more qualified individuals to the research ranks.
The New Year is a time during which most of us celebrate the idea of fresh starts. It’s also a time of reflection. In the spirit of this New Year, Dermatology Times asked several top dermatologists to ponder their legacies.
A recent study provides more evidence that patients with psoriasis–even mild cases–face a higher risk of major depression, a finding that could lead dermatologists to alert patients with the condition and even screen them for mental health issues.
Cancer treatments are expected to dominate much of the first wave of biosimilars in the U.S. This Q&A discussion looks at some of the questions pharmacists have about use of biosimilars in cancer treatment.